Skip to main content
Premium Trial:

Request an Annual Quote

Ben Kaplan, Joseph Keyes


Genaissance Pharmaceuticals has appointed Ben Kaplan senior vice president and chief financial officer. He succeeds Joseph Keyes, who is resigning as CFO to “pursue other interests.” Kaplan, 46, comes to Genaissance from a six-month stint as senior vice president for finance and administration and CFO at Ikonisys, a small diagnostic company. He was also a consultant to PerkinElmer, and was vice president and CFO at Packard Bioscience.


Filed under

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.